Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease

EM Rocha, B De Miranda, LH Sanders - Neurobiology of disease, 2018 - Elsevier
… , role in lysosomal dysfunction and activation of the … recent evidence linking α-synuclein
and mitochondrial dysfunction in … between α-synuclein and mitochondrial dysfunction may …

[HTML][HTML] α-Synuclein and mitochondrial dysfunction in Parkinson's disease

S Mullin, A Schapira - Molecular neurobiology, 2013 - Springer
α-Synuclein (SNCA) is a substantive component of Lewy bodies, … , mitochondrial dysfunction
and impaired regulation of protein turnover interact to cause dopaminergic cell dysfunction

Mitochondrial Dysfunction and αSynuclein Synaptic Pathology in Parkinson's Disease: Who's on First?

…, M Pizzi, C Missale, PF Spano, A Bellucci - Parkinson's …, 2015 - Wiley Online Library
… a link between α-synuclein deposition and the onset of impaired mitochondrial homeostasis,
… This suggests that both α-synuclein pathology and mitochondrial impairment may very well …

Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein

SR Subramaniam, L Vergnes, NR Franich, K Reue… - Neurobiology of …, 2014 - Elsevier
mitochondrial complex I activity assay by ELISA confirmed a 40% inhibition specifically in the
ventral midbrain. Mitochondrial dysfunctionsynuclein. Thus, in mice over-expressing alpha-…

Targeting αsynuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease

ME Haque, M Akther, S Azam, IS Kim… - British Journal of …, 2022 - Wiley Online Library
… Previously, most of the studies focused on the mitochondrial dysfunctionmitochondrial
dysfunction modulates α-synuclein aggregation or α-synuclein causes mitochondrial dysfunction. …

An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered α-synuclein metabolism and oxidative damage

TB Sherer, R Betarbet, AK Stout, S Lund… - Journal of …, 2002 - Soc Neuroscience
Chronic systemic complex I inhibition caused by rotenone exposure induces features of
Parkinson's disease (PD) in rats, including selective nigrostriatal dopaminergic degeneration …

Mitochondrial dysfunction: the road to alphasynuclein oligomerization in PD

AR Esteves, DM Arduino, DFF Silva… - Parkinson's …, 2011 - Wiley Online Library
Mitochondria are remarkably … on mitochondrial dysfunction-mediated alpha-synuclein
aggregation. We highlight some of the findings that provide proof of evidence for a mitochondrial

Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease

D Grassi, S Howard, M Zhou… - Proceedings of the …, 2018 - National Acad Sciences
mitochondrial pathology in PD (39, 40). However, the neurotoxic mechanisms underlying
mitochondrial dysfunction … the deposition of abnormal α-syn and mitochondrial damage has not …

[HTML][HTML] Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases

L Devi, HK Anandatheerthavarada - Biochimica et Biophysica Acta (BBA) …, 2010 - Elsevier
… To test the presence of α synuclein in mitochondria of dopaminergic neurons of PD brains,
we carried out using triple immuno staining on deparaffinised tissue sections from …

[HTML][HTML] TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease

A Bender, P Desplats, B Spencer, E Rockenstein… - PloS one, 2013 - journals.plos.org
α-Syn-induced mitochondrial toxicity. We show that α-Syn causes mitochondrial dysfunction
… We present evidence showing that oxidative stress and impaired mitochondrial function are …